In April, we added 99 citations in DIDB, including 51 in vitro (with 16 articles published in April 2024) and 48 in vivo articles (with 28 articles published in April 2024).
2 NDAs approved in 2024, including givinostat (DUVYZAT) and resmetirom (REZDIFFRA), were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.